Gastrointestinal Neoplasm clinical trials

Explore recruiting gastrointestinal neoplasm clinical trials.

Recruiting gastrointestinal neoplasm studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gastrointestinal Neoplasm trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(22752) A Phase 2 open-label basket study to evaluate the efficacy and safety of orally administered reversible tyrosine kinase inhibitor BAY 2927088 in participants with metastatic or unresectable solid tumors with HER2-activating mutations

Spain, Denmark, Italy, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Gastrointestinal Neoplasm trials by city

Gastrointestinal Neoplasm clinical trials

Recruiting gastrointestinal neoplasm studies right now

Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced HCC

A Study of Standard Of Care Versus Radio Ablation in Early Stage HCC

Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk

Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

Effects of High-Fiber Diet on Gut Microbiota, Metabolism, and Immune Microenvironment in Solid Tumor Patients: A Clinical Study

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

Optical Biopsy for Peritoneal Nodules in Colorectal Patients

Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases

Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW)

Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.

TheraSphere Japan Pre-Market Study

Also recruiting in Europe

(22752) A Phase 2 open-label basket study to evaluate the efficacy and safety of orally administered reversible tyrosine kinase inhibitor BAY 2927088 in participants with metastatic or unresectable solid tumors with HER2-activating mutations

Gastrointestinal Neoplasm trials by city

Other conditions